A Case of Pancreatic Neuroendocrine Tumor G3 Which Responded Remarkably to Chemotherapy.
NEC
NET G3
neuroendocrine neoplasms (NENs)
streptozocin
Journal
Journal of UOEH
ISSN: 0387-821X
Titre abrégé: J UOEH
Pays: Japan
ID NLM: 7909645
Informations de publication
Date de publication:
2022
2022
Historique:
entrez:
11
9
2022
pubmed:
12
9
2022
medline:
14
9
2022
Statut:
ppublish
Résumé
Pancreatic neuroendocrine carcinoma (NEC) as classified in the World Health Organization (WHO) 2010 was reclassified in the WHO 2017 as either neuroendocrine tumor (NET) G3 or NEC. An accurate diagnosis based on the WHO 2017 classification is important in order treating this disease appropriately. We report a case diagnosed as NET G3 that responded remarkably well to treatment with streptozocin. The patient would likely not have received the streptozocin treatment if she had been diagnosed with NEC. The WHO 2017 classification is reasonable for the treatment of advanced pancreatic neuroendocrine neoplasms.
Identifiants
pubmed: 36089347
doi: 10.7888/juoeh.44.287
doi:
Substances chimiques
Streptozocin
5W494URQ81
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM